STOCK TITAN

Cybin to Participate in the 2022 Maxim Group Virtual Growth Conference on March 28-30, 2022

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Cybin, a biopharmaceutical company focused on mental health therapeutics, announced that CEO Doug Drysdale will present at the 2022 Virtual Growth Conference from March 28 to 30, 2022. The presentation will be available on demand starting March 28 at 9:00 a.m. ET. Interested attendees can register to access the conference and listen to the presentation via the company's website. Founded in 2019 and headquartered in Canada, Cybin is dedicated to advancing psychedelics for therapeutic use through innovative drug discovery and delivery systems.

Positive
  • None.
Negative
  • None.

TORONTO--(BUSINESS WIRE)-- Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) (“Cybin” or the “Company”), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics™” is pleased to announce that Doug Drysdale, Cybin’s Chief Executive Officer, will present at the 2022 Virtual Growth Conference, presented by Maxim Group LLC and hosted by M-Vest, taking place March 28th - 30th from 9:00 a.m. - 5:00 p.m. ET.

Mr. Drysdale’s presentation will be available on demand beginning at 9:00 a.m. ET on Monday, March 28th. To attend, please register here to access the conference. To listen to the presentation, please click here to access the webcast. The archived webcast will also be available on the Company’s investor relations website on the Events & Presentations page.

About Cybin
Cybin is a leading ethical biopharmaceutical company, working with a network of world-class partners and internationally recognized scientists, on a mission to create safe and effective therapeutics for patients to address a multitude of mental health issues. Headquartered in Canada and founded in 2019, Cybin is operational in Canada, the United States, United Kingdom and Ireland. The Company is focused on progressing Psychedelics to Therapeutics by engineering proprietary drug discovery platforms, innovative drug delivery systems, novel formulation approaches and treatment regimens for mental health disorders.

Investor & Media:

Leah Gibson

Vice President, Investor Relations

Cybin Inc.

leah@cybin.com

Source: Cybin Inc.

FAQ

When will Cybin's CEO Doug Drysdale present at the Virtual Growth Conference?

Doug Drysdale will present at the Virtual Growth Conference from March 28 to 30, 2022.

How can I access Doug Drysdale's presentation for Cybin?

You can access Doug Drysdale's presentation starting March 28 at 9:00 a.m. ET by registering for the conference.

What is Cybin's focus as a biopharmaceutical company?

Cybin focuses on progressing psychedelics to therapeutics to address mental health issues.

Where is Cybin headquartered?

Cybin is headquartered in Canada.

What are the dates for the 2022 Virtual Growth Conference?

The 2022 Virtual Growth Conference will take place from March 28 to 30, 2022.

Cybin Inc.

NYSE:CYBN

CYBN Rankings

CYBN Latest News

CYBN Stock Data

202.33M
19.99M
6.35%
38.41%
3.28%
Biotechnology
Healthcare
Link
United States of America
Toronto